Novel biomarkers identifying hypertrophic cardiomyopathy and its obstructive variant based on targeted amino acid metabolomics-Reference-Cited by-同舟云学术

Novel biomarkers identifying hypertrophic cardiomyopathy and its obstructive variant based on targeted amino acid metabolomics

Published:2022-08-20 Issue:16 Volume:135 Page:1952-1961
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Guo Lanyan,Wang Bo,Zhang Fuyang,Gao Chao,Hu Guangyu,Zhou Mengyao,Wang Rutao,Zhao Hang,Yan Wenjun,Zhang Ling,Ma Zhiling,Yang Weiping,Guo Xiong,Huang Chong,Cui Zhe,Sun Fangfang,Song Dandan,Liu Liwen,Tao Ling

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference47 articles.

1. Clinical course and management of hypertrophic cardiomyopathy;Maron;N Engl J Med,2018

2. New perspectives on the prevalence of hypertrophic cardiomyopathy;Semsarian;J Am Coll Cardiol,2015

3. Occurrence of clinically diagnosed hypertrophic cardiomyopathy in the United States;Maron;Am J Cardiol,2016

4. Disparities in the diagnosis of hypertrophic obstructive cardiomyopathy: a narrative review of current literature;Burns;Cardiol Res Pract,2018

5. Variability of left ventricular outflow tract gradient during cardiac catheterization in patients with hypertrophic cardiomyopathy;Geske;JACC Cardiovasc Interv,2011

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Classification of Cardiovascular Diseases from Magnetic Resonance Imaging using Classifiers;2024 International Conference on Smart Systems for Electrical, Electronics, Communication and Computer Engineering (ICSSEECC);2024-06-28

2. Identification and validation of pyroptosis-related genes as potential biomarkers for hypertrophic cardiomyopathy: A comprehensive bioinformatics analysis;Medicine;2024-01-26